
GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict
Fox News
The World Health Organization releases its first official guidance on GLP-1 therapies for obesity, recommending a comprehensive approach with behavioral interventions.
"Our new guidance recognizes that obesity is a chronic disease that can be treated with comprehensive and lifelong care." Angelica Stabile is a lifestyle reporter for Fox News Digital.
The first guideline, released on Dec. 1, aims to address the "growing global health challenge of obesity," WHO wrote in a press release.
More Related News













